ETF Battles: Which Biotech Stock ETF is the Better Choice? – It’s IBB vs. XBI!

In this episode of ETF Battles, you’ll watch an audience requested biotech clash between the iShares Biotechnology ETF (IBB) vs. the SPDR S&P Biotech ETF (XBI). Which biotech stock fund is the better choice?

Ron DeLegge @ETFguide referees this biotech duel with guest judges Jessica Ferringer from and Eric Balchunas at Bloomberg sharing their research insights.

Each ETF is judged against the other in key categories like cost, exposure strategy, performance, yield and a mystery category. Find out who wins the battle!

ETF Battles is sponsored by:
Direxion Daily Leveraged & Inverse ETFs. If you’re ready for a bold trade, visit

Get in touch with our judges:

Free ETF Guides
Get help with your investing habits
Enroll in online classes built for investors
Get feedback on your portfolio’s risk
Check your investment performance
60 Smart Ways to Retire Better

1) Spotify

2) iTunes
3) Amazon Music
4) Google Podcasts

#BiotechETF #CovidStocks#BiotechStocks

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Do You Want To Boost Your Business?

drop us a line and keep in touch